https://www.germanhealthreview.com/article/908795271-nerds-on-site-inc-reports-q3-fy2026-results-return-to-profitability-and-continued-revenue-momentum German Health Review en PressRelease 2026-04-28T20:30:00+00:00 NERDS ON SITE INC. REPORTS Q3 FY2026 RESULTS: RETURN TO PROFITABILITY AND CONTINUED REVENUE MOMENTUM https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/22387801-30th-anniv-logo-2452x1732.png https://www.germanhealthreview.com/article/908436122-vocic-releases-a-rollator-walker-that-transforms-for-travel German Health Review en PressRelease 2026-04-28T14:30:00+00:00 VOCIC Releases a Rollator Walker That Transforms for Travel https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24841524-vocic-packgo-rollator-walker-z3-1755x918.jpeg https://www.germanhealthreview.com/article/905904291-innere-f-hrung-als-neue-form-von-exzellenz German Health Review en PressRelease 2026-04-28T12:56:25+00:00 Innere Führung als neue Form von Exzellenz https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24833369-der-wandel-kommt-aus-unserm-inn-1080x1080.png https://www.germanhealthreview.com/article/908717961-cytespace-africa-laboratories-brings-ngs-in-region-to-eliminate-delays-in-african-clinical-trials German Health Review en PressRelease 2026-04-28T12:14:08+00:00 Cytespace Africa Laboratories Brings NGS In-Region to Eliminate Delays in African Clinical Trials https://www.germanhealthreview.com/article/908719486-inflarx-regains-compliance-with-nasdaq-minimum-bid-price-requirement German Health Review en PressRelease 2026-04-28T11:30:00+00:00 InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png https://www.germanhealthreview.com/article/908713051-mbiomics-announces-third-closing-of-series-a-reaching-30-million-to-advance-microbiome-therapeutics German Health Review en PressRelease 2026-04-28T11:00:00+00:00 mbiomics Announces Third Closing of Series A, Reaching €30 Million to Advance Microbiome Therapeutics https://ml.globenewswire.com/media/8c035ff9-fe7b-4b6d-ad71-126bf3ad30fe/small/mbiomics-logo-orange-rgb-png.png https://www.germanhealthreview.com/article/908507540-italian-ceo-elena-salda-issues-global-appeal-to-redefine-the-future-of-manufacturing-for-gen-z German Health Review en PressRelease 2026-04-27T18:37:42+00:00 ITALIAN CEO ELENA SALDA ISSUES GLOBAL APPEAL TO REDEFINE THE FUTURE OF MANUFACTURING FOR GEN Z https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/20499904-elena-salda-ceo-of-cms-1707x2560.jpeg https://www.germanhealthreview.com/article/908661451-boehringer-ingelheim-s-novel-glucagon-glp-1-dual-agonist-survodutide-achieved-significant-weight-loss-of-16-6-delivering-meaningful-metabolic German Health Review en PressRelease 2026-04-28T06:00:00+00:00 Boehringer Ingelheim’s novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with obesity or overweight in Phase III trial https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png https://www.germanhealthreview.com/article/908381945-chinese-top-3-hyperbaric-oxygen-chamber-manufacturers-in-2026-pioneering-global-hbot-innovation-safety-standards German Health Review en PressRelease 2026-04-27T06:21:05+00:00 Chinese Top 3 Hyperbaric Oxygen Chamber Manufacturers in 2026: Pioneering Global HBOT Innovation & Safety Standards https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24841296-logo-for-guangdong-gihomo-medic-800x800.png